ALYA

Qualification

Tell us enough to say yes or no, fast.

Nine fields, five minutes. A clear answer within ten business days, and the review costs nothing. Confidential on both sides.

What we look for

  • MedTech, BioTech or diagnostics with clinical evidence — Phase 1 safety data or equivalent at minimum

  • A credible path to revenue within the royalty term

  • Raising $1M–$10M for a trial, regulatory milestone or commercial launch

  • Relevance to the region's health priorities is a strong plus — diabetes, cardiovascular, hereditary and genomic conditions

Required

Submitting opens a pre-filled email from your own mail client — nothing is stored on this site. We reply within ten business days.